Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2059 of 6351
-
Patch may boost fetal spina bifida repair, early trial hints
Disease control OngoingThe purpose of the study is to compare the maternal, fetal and neonatal outcomes of a cohort of 60 patients in whom a multilayer closure with a Durepair patch is performed with a prior cohort of patients in whom a standardized repair without patch (n = 32) was performed using the…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Gene therapy hope for pompe patients in early safety trial
Disease control CompletedOpen-label, ascending dose trial of ACTUS-101 administered intravenously.
Phase 1 • Sponsor: AskBio Inc • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Experimental gene injection targets dry AMD
Disease control Stopped earlyThis was an open label first in human Phase I/II multicentre study of GT005 in subjects with Macular Atrophy due to Age-related macular degeneration (AMD).
Phase 1/2 • Sponsor: Gyroscope Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Shorter radiation course may reduce side effects for lung cancer patients
Disease control Recruiting nowThis study's goal is to find out if the kind of side effects people experience from radiation is different depending on the schedule of their radiation treatment. Patients will be randomly assigned to either the 3 Fraction or 5 Fraction schedule of radiation. After patients compl…
Sponsor: University of Rochester • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New pill shows promise for Hard-to-Treat neuroendocrine tumors
Disease control OngoingCVM-1118 (TRX-818) is a new small molecule chemical entity being developed as a potential anti-cancer therapeutic by TaiRx, Inc. CVM-1118 is a potent anti-cancer agent in numerous human cancer cell lines. The safety of administrating CVM-1118 on human is evaluated from the phase …
Phase 2 • Sponsor: TaiRx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Triple-Drug chemo blitz aims to boost stomach cancer survival
Disease control OngoingIn this clinical trial, patients with gastric and gastroesophageal junction adenocarcinoma will be included. Treatment with curative intent will be given with chemotherapy for 4 cycles with fluorouracil, oxaliplatin and irinotecan preoperatively followed by surgery, and then addi…
Phase 2 • Sponsor: Lund University Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:23 UTC
-
A blood clue to a rare vessel disease?
Knowledge-focused CompletedThe study aims at defining the role of soluble CD95 Ligand in the physiopathology of a rare group of inflammatory diseases: ANCA associated vasculitis. Soluble CD95 Ligand might have a prognostic and diagnostic interest as well as potential for the discovery of new therapeutic st…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
New combo therapy shows promise for tough bladder cancer
Disease control Stopped earlyThis research study is studying the effects of adding a certain type of immunotherapy to standard bladder-directed radiation as a treatment for muscle-invasive urothelial carcinoma of the bladder. The drug in this study is: Avelumab (also known as BAVENCIO®)
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug combo shows promise in early trial for advanced melanoma
Disease control OngoingThis pilot phase I trial studies how well VX15/2503 (pepinemab) with or without ipilimumab and/or nivolumab work in treating participants with stage IIIB-D melanoma that can be removed by surgery. Monoclonal antibodies, such as VX15/2503, ipilimumab, and nivolumab may interfere w…
Phase 1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New study pits CESM against MRI for breast cancer detection
Diagnosis CompletedThe main objective of this study is to compare the diagnostic performance of two diagnostic methods, namely CESM and MRI, in the evaluation of a lesion suspicious of breast cancer in 300 Quebec women referred for the investigation of breast cancer. breast lesion suspected of canc…
Sponsor: CHU de Quebec-Universite Laval • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Can a VR headset replace some sedatives during surgery?
Symptom relief CompletedWe will investigate whether the use of Virtual Reality (VR) preoperatively and intraoperatively can help treat pain and anxiety, as measured by patient feedback, vital signs trends, and the amounts of anesthetics, pain medications and anxiolytics used during surgical procedures. …
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
New hope for ovarian cancer patients resistant to PARP inhibitors
Disease control OngoingThis phase II trial studies how well adavosertib with or without olaparib work in treating patients with ovarian, primary peritoneal, or fallopian tube cancer that has come back (recurrent). Adavosertib and olaparib may stop the growth of tumor cells by blocking some of the enzym…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New biologic drug brazikumab tested for Crohn's – trial cut short
Disease control Stopped earlyThis study seeks to evaluate the safety and efficacy of brazikumab versus placebo (Stage I) and versus an active comparator (Stage 2) in participants with moderately to severely active CD and will include assessments of clinical response as demonstrated by improvement of symptoms…
Phase 2/3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a daily sugar dose help kids with rare CDG?
Disease control CompletedResearchers are trying to assess whether the use of simple sugars given as a daily dietary supplement can improve the health of children with congenital disorders of glycosylation (CDG).
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can a new nerve block ease pain after lung surgery?
Symptom relief CompletedThis study will compare ESP block plus patient-controlled analgesia (PCA) to intercostal nerve block plus PCA as post-operative pain control for patients having video-assisted thorascopic surgeries.
Sponsor: McMaster University • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Can medical records unlock the secrets of rare calcification diseases?
Knowledge-focused CompletedThe purpose of this study is to characterize the natural history of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) Deficiency and the early-onset form of adenosine triphosphate binding cassette transporter subfamily C member 6 (ABCC6) Deficiency through retrospective …
Sponsor: Inozyme Pharma • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Can a drug wake up the immune system in kids with sepsis?
Disease control CompletedThis study is an open-label, multi-center, interventional trial in which children with sepsis-induced MODS undergo surveillance immune function testing beginning on Day 2 of MODS. Those children who demonstrate immunoparalysis (TNF-alpha response \<200 pg/ml) will receive a 7-day…
Phase 4 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Brain scans may reveal why some with cerebral palsy feel chronic pain
Knowledge-focused Recruiting nowThe investigators hope to use MRI biomarkers to identify and characterize sensorimotor network disruption patterns associated with chronic pain and sensory deficits in CP. Investigators will use existing information in the medical record as well as subjective reports from intervi…
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
New combo therapy for aggressive brain cancer shows promise in early trial
Disease control CompletedThis phase II trial studies how well whole brain radiation therapy works with standard temozolomide chemo-radiotherapy and plerixafor in treating patients with glioblastoma (brain tumor). Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Drugs used …
Phase 2 • Sponsor: Lawrence D Recht • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Home test for gut inflammation could cut flares in ulcerative colitis
Disease control CompletedHypothesis: Pro-active home fecal calprotectin testing in patients with Ulcerative Colitis will allow early detection and treatment of inflammation to prevent symptomatic flares. This will result in less steroid use, fewer hospitalizations and a reduced risk of surgery, as well …
Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC